A.R.T. Advisors LLC Invests $116,000 in Tandem Diabetes Care Inc (TNDM)

A.R.T. Advisors LLC bought a new position in Tandem Diabetes Care Inc (NASDAQ:TNDM) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 54,100 shares of the medical device company’s stock, valued at approximately $116,000. A.R.T. Advisors LLC owned approximately 0.18% of Tandem Diabetes Care at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Tocqueville Asset Management L.P. increased its stake in shares of Tandem Diabetes Care by 3.0% in the third quarter. Tocqueville Asset Management L.P. now owns 101,400 shares of the medical device company’s stock valued at $777,000 after buying an additional 3,000 shares during the last quarter. State Street Corp increased its stake in shares of Tandem Diabetes Care by 2.5% in the fourth quarter. State Street Corp now owns 232,147 shares of the medical device company’s stock valued at $499,000 after buying an additional 5,645 shares during the last quarter. Iguana Healthcare Management LLC increased its stake in shares of Tandem Diabetes Care by 5.7% in the third quarter. Iguana Healthcare Management LLC now owns 185,000 shares of the medical device company’s stock valued at $1,417,000 after buying an additional 10,000 shares during the last quarter. Keybank National Association OH increased its stake in shares of Tandem Diabetes Care by 99.8% in the fourth quarter. Keybank National Association OH now owns 69,537 shares of the medical device company’s stock valued at $150,000 after buying an additional 34,726 shares during the last quarter. Finally, Wrapmanager Inc. increased its stake in shares of Tandem Diabetes Care by 138.3% in the fourth quarter. Wrapmanager Inc. now owns 60,539 shares of the medical device company’s stock valued at $130,000 after buying an additional 35,135 shares during the last quarter. Institutional investors own 56.79% of the company’s stock.

Institutional Ownership by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care Inc (NASDAQ:TNDM) traded up 0.7885% during mid-day trading on Friday, hitting $0.9587. The stock had a trading volume of 320,874 shares. Tandem Diabetes Care Inc has a 52-week low of $0.94 and a 52-week high of $11.30. The firm has a 50-day moving average of $1.54 and a 200-day moving average of $2.84. The stock’s market cap is $30.04 million.

Tandem Diabetes Care (NASDAQ:TNDM) last released its quarterly earnings results on Wednesday, March 8th. The medical device company reported ($0.48) EPS for the quarter, topping analysts’ consensus estimates of ($0.65) by $0.17. Tandem Diabetes Care had a negative net margin of 95.57% and a negative return on equity of 220.14%. The company had revenue of $24.80 million for the quarter, compared to the consensus estimate of $22.75 million. During the same period in the previous year, the firm earned ($0.40) EPS. Tandem Diabetes Care’s revenue was down 14.8% on a year-over-year basis. On average, analysts forecast that Tandem Diabetes Care Inc will post ($1.79) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “A.R.T. Advisors LLC Invests $116,000 in Tandem Diabetes Care Inc (TNDM)” was originally posted by BBNS and is owned by of BBNS. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://baseballnewssource.com/markets/54100-shares-in-tandem-diabetes-care-inc-tndm-acquired-by-a-r-t-advisors-llc-updated-updated/525797.html.

TNDM has been the topic of several recent analyst reports. Zacks Investment Research upgraded Tandem Diabetes Care from a “hold” rating to a “buy” rating and set a $2.50 price target on the stock in a report on Tuesday, March 14th. Wedbush reiterated a “positive” rating on shares of Tandem Diabetes Care in a report on Tuesday, January 24th. B. Riley downgraded Tandem Diabetes Care from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $5.00 to $1.50 in a report on Friday, March 24th. Northcoast Research reissued a “buy” rating on shares of Tandem Diabetes Care in a research note on Thursday, March 9th. Finally, Piper Jaffray Companies reissued a “neutral” rating on shares of Tandem Diabetes Care in a research note on Thursday, March 30th. Seven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $5.63.

In related news, CEO Kim D. Blickenstaff purchased 1,600,000 shares of the company’s stock in a transaction on Thursday, March 23rd. The shares were bought at an average cost of $1.25 per share, for a total transaction of $2,000,000.00. Following the transaction, the chief executive officer now owns 2,007,939 shares of the company’s stock, valued at $2,509,923.75. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 37.10% of the stock is currently owned by insiders.

About Tandem Diabetes Care

Tandem Diabetes Care, Inc is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4).

5 Day Chart for NASDAQ:TNDM

Receive News & Ratings for Tandem Diabetes Care Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tandem Diabetes Care Inc and related companies with our FREE daily email newsletter.

 

Latest News

Sources Say Luis Robert Will Be Cleared by May 20 to Sign
Sources Say Luis Robert Will Be Cleared by May 20 to Sign
Colorado Rockies Bullpen Helping Them to NL West Lead
Colorado Rockies Bullpen Helping Them to NL West Lead
Hall of Famer Given New Lease on Life
Hall of Famer Given New Lease on Life
New York Mets Have the Power
New York Mets Have the Power
Red Sox Fighting Through Illness and Injury
Red Sox Fighting Through Illness and Injury
Cleveland and Arizona Off to Fast Starts
Cleveland and Arizona Off to Fast Starts


Leave a Reply

 
© 2006-2017 BBNS.